Viral proteases activate the CARD8 inflammasome in the human cardiovascular system
- J Exp Med. 2022 Oct 3;219(10):e20212117. doi: 10.1084/jem.20212117.
- 1. Duke-NUS Medical School, Program in Cardiovascular and Metabolic Disorders, Singapore, Singapore.
- 2. Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada.
- 3. Lee Kong Chian School of Medicine, Nanyang Technological University Singapore, Singapore, Singapore.
- 4. Skin Research Institute of Singapore, A*STAR, Singapore, Singapore.
- 5. Institute of Molecular and Cell Biology, A*STAR, Singapore, Singapore.
- # Contributed equally.
Nucleotide-binding oligomerization domain (NBD), leucine-rich repeat (LRR) containing protein family (NLRs) are intracellular Pattern Recognition Receptors that mediate innate immunity against infections. The endothelium is the first line of defense against blood-borne pathogens, but it is unclear which NLRs control endothelial cell (EC) intrinsic immunity. Here, we demonstrate that human ECs simultaneously activate NLRP1 and CARD8 inflammasomes in response to DPP8/9 inhibitor Val-boro-Pro (VbP). Enterovirus Coxsackie virus B3 (CVB3)-the most common cause of viral myocarditis-predominantly activates CARD8 in ECs in a manner that requires viral 2A and 3C protease cleavage at CARD8 p.G38 and Proteasome function. Genetic deletion of CARD8 in ECs and human embryonic stem cell-derived cardiomyocytes (HCMs) attenuates CVB3-induced Pyroptosis, inflammation, and viral propagation. Furthermore, using a stratified endothelial-cardiomyocyte co-culture system, we demonstrate that deleting CARD8 in ECs reduces CVB3 Infection of the underlying cardiomyocytes. Our study uncovers the unique role of CARD8 inflammasome in endothelium-intrinsic anti-viral immunity.
-
Cat. No.Product NameDescriptionTargetResearch Area
-
-
target: CaspaseResearch Areas: Inflammation/Immunology
-
target: Dipeptidyl Peptidase